Hubungan Kadar HbA1c Dan Rasio TG/HDL Dengan Cystatin-C Serum Pada Pasien Diabetes Melitus Tipe 2

Authors

  • Hadian Widyatmojo Bagian Patologi Klinis Fakultas Kedokteran Universitas Diponegoro Semarang, Indonesia
  • Indranila Kustarini Samsuria Bagian Patologi Klinis Fakultas Kedokteran Universitas Diponegoro, Indonesia
  • Ria Triwardhani Bagian Patologi Klinis RSUP Dr. Kariadi Semarang, Indonesia

DOI:

https://doi.org/10.36408/mhjcm.v6i2.388

Abstract

Latar belakang: Diabetes melitus (DM)  tipe 2 dapat menyebabkan komplikasi salah satunya nefropati. Kontrol glikemik yang dinilai dengan HbA1c dan dislipidemia yang dinilai dengan rasio trigliserida/high density lipoprotein (TG/HDL) diduga berhubungan dengan komplikasi nefropati. Cystatin C merupakan petanda yang dapat menilai kerusakan fungsi ginjal dini. Hubungan kadar HbA1c dan rasio TG/HDL dengan Cystatin C pada pasien DM tipe 2 belum diketahui dengan jelas.

Tujuan: Mengetahui hubungan antara kadar HbA1c dan rasio TG/HDL dengan Cystatin C pada pasien diabetes melitus tipe 2.

Metode: Penelitian observasional analitik dengan pendekatan belah lintang dilakukan pada bulan April - Juni 2019 melibatkan 34 pasien DM tipe 2 di Puskesmas Karang Ayu yang memenuhi kriteria inklusi dan ekslusi. Pemeriksaan kadar HbA1c menggunakan metode HPLC, rasio TG/HDL dihitung dengan perbandingan TG dengan HDL yang diperiksa menggunakan alat kimia klinik otomatis, kadar Cystatin C menggunakan metode ELISA. Uji statistik menggunakan korelasi Spearman. p < 0,05 dianggap signifikan. 

Hasil: Rerata±SD kadar HbA1c adalah 8,21±1,65. Median (minimum-maksimum) rasio TG/HDL dan Cystatin C berturut-turut adalah 3,65(1,3–9,7), 0,72(0,46 – 1,22) mg/L. Korelasi HbA1c dengan Cystatin C dan rasio TG/HDL dengan Cystatin C berturut-turut adalah (r = 0,505; p = 0,002) dan (r = 0,471; p = 0,005).

Simpulan: Terdapat hubungan positif sedang bermakna antara kadar HbA1c dengan Cystatin C  dan rasio TG/HDL dengan Cystatin C pada pasien diabetes melitus tipe 2.

Kata kunci: HbA1c, rasio TG/HDL, Cystatin C, DM.

 

The correlation of HbA1c and TG/HDL ratio with serum cystatin C in type 2 diabetes patients

 

Background: Type 2 diabetes mellitus (DM) can cause chronic complications such as nephropathy. Glycemic control assessed with HbA1c and dyslipidemia assessed by the tryglyceride/high density lipoprotein (TG / HDL) ratio is thought to be associated with complications of nephropathy. Cystatin C is a marker that can assess early kidney function damage. Relationship between HbA1c levels and TG / HDL ratio with Cystatin C in type 2 DM patients is not clearly known.

Objective: to investigate the correlation of HbA1c and TG/HDL ratio with Cystatin C  in acute type 2 diabetes mellitus patients.

Methods: Analytic observational study with cross sectional approach was conducted in April-June 2019 involving 34 type 2 diabetes mellitus patients at the Karang Ayu Puskesmas who were screened according to the inclusion and exclusion criteria. The level of HbA1c were measured by the HPLC method, TG/HDL ratio was measured by automatic chemistry analyzer and Cystatin C was measured by ELISA method. Statistical analysis used Spearman Correlation Test. p <0.05 was considered significant.

Results: The mean ± SD HbA1c level was 8.21 ± 1.65. The median (minimum-maximum) ratio of TG / HDL and Cystatin C were 3.65 (1.3–9.7), 0.72 (0.46 - 1.22) mg / L, respectively. Correlation of HbA1c with Cystatin C and the ratio of TG / HDL with Cystatin C respectively (r = 0.505; p = 0.002) and (r = 0.471; p = 0.005).

Conclusions: There are significant moderate positive correlation between HbA1c with  Cystatin C and TG/HDL ratio with Cystatin C in type 2 diabetes mellitus patients.

Keywords : HbA1c, TG/HDL ratio, Cystatin C, Type 2 Diabetes mellitus.

Downloads

Download data is not yet available.

Additional Files

Published

2019-11-20

How to Cite

1.
Widyatmojo H, Samsuria IK, Triwardhani R. Hubungan Kadar HbA1c Dan Rasio TG/HDL Dengan Cystatin-C Serum Pada Pasien Diabetes Melitus Tipe 2. Medica Hospitalia J. Clin. Med. [Internet]. 2019 Nov. 20 [cited 2024 Dec. 3];6(2):86-91. Available from: http://medicahospitalia.rskariadi.co.id/medicahospitalia/index.php/mh/article/view/388

Issue

Vol. 6 No. 2 (2019): Med Hosp; Nov 2019

Section

Original Article

Citation Check

License

Copyright (c) 2019 Medica Hospitalia : Journal of Clinical Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.